Home » Topics » BioWorld

BioWorld
RSS

GILEAD IPO RAISES $86.25 MILLION

Jan. 23, 1992

CALGENE TO TEST LAURATE-PRODUCING PLANT

Jan. 23, 1992

DNAP TOMATOES RESIST ROT

Jan. 23, 1992

USDA OKS CARRINGTON VACCINE ADJUVANT

Jan. 23, 1992

LIDAK CANCELS PLANS FOR SUBSIDIARY

Jan. 23, 1992

DOCTORS BLAST AMGEN'S G-CSF TRIAL

Jan. 23, 1992

YAMANOUCHI TO BUY STAKE IN ROBERTS

Jan. 23, 1992

SOMATIX GETS PATENT FOR GENE THERAPY

Jan. 23, 1992

IMMULOGIC RAISES $45.5 MILLION IN OFFERING

Jan. 22, 1992

INTERNEURON LICENSES DELIVERY TECHNOLOGY

Jan. 22, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...